Pain Management Therapeutics Market Share, Size and Analysis Report 2022-2029

1. Rising Incidence of Chronic Diseases and Life-threatening Cancers to Contribute to Pain Management Therapeutics Market Growth The growing incidence of critical illnesses has led to chronic pain becoming a more pervasive tendency. Therefore, the rise in the number of people suffering from chronic disorders and the pain associated with them has pushed healthcare bodies to create new and efficient pain management therapeutics. Some of the common ailments such as chronic back pain, neuropathic pain, arthritic pain, cancer pain, and post-operative pain are creating new opportunities for growth within the pain management therapeutic market. It is vital for pharmaceutical companies to ensure high efficacy and efficiency of these therapeutics. The success of each therapeutic medication depends on its prolonged effect on the body. Increase in Cancer Cases Calls for Better Pain Management Therapeutics Cancer has always been a fatal disease and a cause of major health concern among healthcare workers and patients alike. With increasing cases of various cancers around the world, the need for better pain management therapeutics has also intensified. Cancer pain has created a great demand for medications such as NSAIDs (Non-Steroidal Anti-Inflammatory Drugs), anticonvulsants, opioids, and anaesthetics. The WHO expects a 75% increase in cancer cases worldwide by 2030. Since making the condition better is essential for the well-being of the patient, this factor will spur demand for pain management therapeutics. This, in turn is creating significant growth prospects for the global pain management therapeutics market. Get Sample Copy ofPain Management Therapeutics Market: https://www.fairfieldmarketresearch.com/report/pain-management-therapeutics- market/request-sample Opioids to Attract Stupendous Demand as a Prescribed Pain-Relief Medication In recent years, doctors have shown a more liberal approach towards prescribing pain-relief medications, especially Opioids. Opioids are assessed to be the highest-selling medications for pain management across wide geographies. They are proven to be extremely effective against cancer pain, making them a sought-after drug in oncology. Ingredients in Opioids such as synthetic and natural opiates make it an efficient solution for pain and trauma caused by surgeries, short-term pain, and acute pain. Owing to the aforementioned factors, it is safe to say Opioids are contributing a significant revenue share in the pain management therapeutics market. During the forecast period, key players are likely to engage in strategic partnerships and open innovation to sustain an edge over the global pain management therapeutics market. Rising Number of Specialist Physicians and Firms Providing Pain Management Therapeutics to Increase Market Demand in North America In the coming years, the demand for pain management therapeutics in North America is likely to increase. The growing presence of specialist physicians and companies providing pain

2. management therapeutics solutions is expected to propel the growth of the regional market. The market is also likely to benefit from the strengthened healthcare infrastructure and the rise of FDA approvals for pain management solutions to patients. Similarly, the Asia Pacific region also shows signs of rising adoption of pain management therapeutics. Surge in deaths due to chronic diseases such as cancer is creating demand for pain management therapeutics in Asia Pacific. Additionally, the availability of cheap labour and land in the region makes it a suitable territory for establishing research facilities for therapeutic drugs. Prominent Market Players Some of the major players in the pain management therapeutics market are AstraZeneca, Mallinckrodt Pharmaceuticals Company, Baxter International Inc., Boston Scientific Corporation, GlaxoSmithKline PLC, Becton Dickinson and Company, Eli Lilly & Company, Abbott Laboratories, Novartis AG, Merck & Co. Inc., Endo Pharmaceuticals Inc., and Teva Pharmaceuticals. For More Information ofPain Management Therapeutics Market: https://www.fairfieldmarketresearch.com/report/pain-management-therapeutics- market About Us Fairfield Market Research is a UK-based market research provider. Fairfield offers a wide spectrum of services, ranging from customized reports to consulting solutions. With a strong European footprint, Fairfield operates globally and helps businesses navigate through business cycles, with quick responses and multi-pronged approaches. The company values an eye for insightful take on global matters, ably backed by a team of exceptionally experienced researchers. With a strong repository of syndicated market research reports that are continuously published & updated to ensure the ever-changing needs of customers are met with absolute promptness. Contact Fairfield Market Research London, UK UK +44 (0)20 30025888 USA (Toll-free) +1 (844) 3829746 Web: https://www.fairfieldmarketresearch.com/ Email: sales@fairfieldmarketresearch.com Follow Us: LinkedIn